Three-dimensional structure of the human protective protein: structure of the precursor form suggests a complex activation mechanism
Open accessAbstract
Background The human 'protective protein' (HPP) forms a multi-enzyme complex with beta-galactosidase and neuraminidase in the lysosomes, protecting these two glycosidases from degradation. In humans, deficiency of HPP leads to the lysosomal storage disease galactosialidosis. Proteolytic cleavage of the precursor form of HPP involves removal of a 2 kDa excision peptide and results in a carboxypeptidase activity. The physiological relevance of this activity is, as yet, unknown. Results The crystal structure of the 108 kDa dimer of the precursor HPP has been elucidated by making extensive use of twofold density averaging. The monomer consists of a 'core' domain and a 'cap' domain. Comparison with the distantly related wheat serine carboxypeptidase dimer shows that the two subunits in the HPP dimer differ by 15 degrees in mutual orientation. Also, the helical subdomain forming part of the cap domains is very different. In addition, the HPP precursor cap domain contains a 'maturation' subdomain of 49 residues which fills the active-site cleft. Merely removing the 'excision' peptide located in the maturation subdomain does not render the catalytic triad solvent accessible. Conclusions The activation mechanism of HPP is unique among proteases with known structure. It differs from the serine proteases in that the active site is performed in the zymogen, but is blocked by a maturation subdomain. In contrast to the zinc metalloproteases and aspartic proteases, the chain segment physically rendering the catalytic triad solvent inaccessible in HPP is not cleaved off to form the active enzyme. The activation must be a multi-step process involving removal of the excision peptide and major conformational changes of the maturation subdomain, whereas the conformation of the enzymatic machinery is probably almost, or completely, unaffected.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Human PPCA has strong sequence similarity to serine carboxypeptidases, and Ser196, His475, and Asp418 were proposed to make up the catalytic triad of an active PPCA enzyme.
“Analysis of the primary structure of human PPCA revealed strong sequence similarity to serine carboxypeptidases, suggesting that the protein had an intrinsic enzymatic activity.”
From Galactosialidosis: historic aspects and overview of investigated and emerging treatment options (2017) · cites this paper as [31]
The Biological implications section reports 30% sequence identity between HPP and wheat and yeast serine carboxypeptidases, and says maturation releases carboxypeptidase activity. The Results and discussion section identifies an HPP catalytic triad, but numbers its residues Ser150, His429 and Asp372—not Ser196, His475 and Asp418 as in the claim. No page numbers are available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No references could be resolved yet.
Research works printed but not linked: 7
- [1]1. d'Azzo, A. ∙ Hoogeveen, A. ∙ Reuser, A.J.J. ... Molecular defect in combined β-galactosidase and neuraminidase deficiency in man Proc. Natl. Acad Sci. USA. 1982; 79:4535-4539 83014923 Crossref Scopus (340) PubMed Google Scholar
- [2]2. Wenger, D.A. ∙ Tarby, T.J. ∙ Wharton, C. Macular cherry-red spots and myoclonus with dementia: co-existent neuraminidase and β-galactosidase deficiencies Biochem. Biophys. Res. Commun. 1978; 82:589-595 Crossref Scopus (167) PubMed Google Scholar
- [5]5. d'Azzo, A. ∙ Andria, G. ∙ Strisciuglio, P. ... Galactosialidosis Scriver ∙ C.R., Beaudet ∙ A.L., Sly ... (Editors) The Metabolic and Molecular Bases of Inherited Disease,vol II McGraw Hill, Inc, New York, 1995; 2825-2837 Google Scholar
- [6]6. Okamura-Oho, Y. ∙ Zhang, S. ∙ Callahan, J.W. The biochemistry and clinical features of galactosialidosis Biochim. Biophys. Acta. 1994; 1225:244-254 94146122 Crossref Scopus (38) PubMed Google Scholar
- [7]7. Thomas, G.H. ∙ Beaudet, A.L. Disorders of glycoprotein degradation and structure: α-mannosidosis, β-mannosidosis, fucosidosis, sialidosis, aspartylglucosaminuria, and carbohydrate-deficient glycoprotein syndrome Scriver ∙ C.R., Beaudet ∙ A.L., Sly ... (Editors) The Metabolic and Molecular Bases of Inherited Disease,vol II McGraw Hill, Inc, New York, 1995; 2529-2561 Google Scholar
- [8]8. Suzuki, Y. ∙ Sakuraba, H. ∙ Oshima, A. β-Galactosidase deficiency (β-galactosidosis): GM1-gangliosidosis and Morquio B disease Scriver ∙ C.R., Beaudet ∙ A.L. Sly ... (Editors) The Metabolic and Molecular Bases of Inherited Disease,vol II McGraw Hill, Inc, New York, 1995; 2785-2823 Google Scholar
- [9]9. Hoogeveen, A.T. ∙ Verheijen, F.W. ∙ Galijaard, H. The relation between human lysosomal β-galactosidase and its protective protein J. Biol. Chem. 1983; 258:12143-12146 84032382
Cited by
Sorted by citations
Cathepsin A–related arteriopathy with strokes and leukoencephalopathy (CARASAL)
Bugiani, M., Kevelam, S. H., Bakels, H. S., Waisfisz, Q., Ceuterick-de Groote, C., Niessen, H. W. M., Abbink, T. E. M., Lesnik Oberstein, S. A. M. J., & van der Knaap, M. S. (2016) · Neurology · doi:10.1212/wnl.0000000000003251 · Cited by 111 · see citing works
Galactosialidosis: historic aspects and overview of investigated and emerging treatment options
Annunziata, I., & d’Azzo, A. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2016.1266933 · Cited by 50 · see citing works
Self-citationStructure of the immunoregulatory sialidase NEU1
Gorelik, A., Illes, K., Mazhab-Jafari, M. T., & Nagar, B. (2023) · Science Advances · doi:10.1126/sciadv.adf8169 · Cited by 36 · see citing works
- Authors
- Rudenko, G., Bonten, E., d'Azzo, A., & GJ Hol, W.
- Affiliations
- University of Washington (US)
- St. Jude Children's Research Hospital (US)
- ORCID
- Rudenko, Gabby
- Venue
- Structure
- Publisher
- Elsevier BV
- Published
- 1995-11
- Volume
- 3
- Issue
- 11
- Pages
- 1249-1259
- ISSN
- 0969-2126 (ISSN-L)
- OpenAlex
- W1984198180
- Cited by
- 97
- References
- 0
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 1 · 2014: 6 · 2013: 2 · 2012: 3
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Structure (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Lebanese Syrian Associated Charities
- National Cancer Institute (P30CA021765)
- Topics
- Physical Sciences › Materials Science › Materials Chemistry › Enzyme Structure and Function
- Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- galactosialidosis, lysosomal storage disease, carboxypeptidase, zymogen activation, catalytic triad, cap domain, core domain, serine protease, protein dimer structure
- MeSH terms
- Amino Acid Sequence, beta-Galactosidase, Carboxypeptidases, Catalysis, Enzyme Activation, Humans, Hydrolases, Lysosomes, Models, Molecular, Molecular Sequence Data, Multienzyme Complexes, Neuraminidase, Protein Conformation, Protein Precursors, Recombinant Fusion Proteins, Structure-Activity Relationship, Lysosomal Storage Diseases, Protein Folding, Crystallography, X-Ray, Cathepsin A, Macromolecular Substances
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review